Skip to main content
SpringerLink
Log in

Practical use of Anticoagulants

  • Chapter
Replacement of Renal Function by Dialysis

Abstract

To use anticoagulants optimally during dialysis it is necessary to understand hemostasis, how to evaluate it and how therapeutic agents interfere with it. Knowledge of the hemostatic defects found in uremia and the influence of dialysis upon these is necessary, as is an understanding of foreign surface induced coagulation. This chapter presents such information before providing a practical guide to anticoagulant use.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Jandl JH: Blood: Textbook of Hematology. Boston, Toronto, Little, Brown, and Co, 1987

    Google Scholar 

  2. Ratnoff O, Forbes CD: Disorders of Hemostasis. Orlando Grune and Stratton Ine, 1984

    Google Scholar 

  3. Schumacher HR, Garvin DF, Triplett DA: Introduction to Laboratory Hematology and Hematopathology. New York, Alan R. Liss Ine, 1984

    Google Scholar 

  4. Dacie Sir JV, Lewis SM: Practical Haematology. 6th edition, Edinburgh, Churchill Livingstone, 1984

    Google Scholar 

  5. Hirsh J: Venous Thromboembolism: Guide to Management. Missisauga, Ontario, DuPont Pharmaceuticals, 1986

    Google Scholar 

  6. Lee GR, Boggs DR, Bithell TC, Foerster J, Athene JW, Lubene JN: Clinical Hematology. Philadelphia, Lea and Febiger, 1981

    Google Scholar 

  7. Bowie EJW, Owen CA Jr: Standardisation of the bleeding time. Scand J Haematol 25 (Suppl 37): 87, 1980

    Google Scholar 

  8. Jorpes JE: Heparin in the Treatment of Thrombosis. An Account of its Chemistry, Physiology and Application in Medicine, London, Oxford University Press, 1946

    Google Scholar 

  9. Cifonelli JA, King J: Structural studies on heparins with unusually high N-acetylglucosamine contents. Biochim Biophys Acta 320: 331, 1973

    PubMed  CAS  Google Scholar 

  10. Rosenberg RD, Lam LH: Heparinized surface - a comment. Ann NY Acad Sci 283: 404, 1977

    CAS  Google Scholar 

  11. O’Reilly RA: Anticoagulant, antithrombotic and thrombolytic drugs, in The Pharmacological Basis of Therapeutics, edited by Gilman AG, Goodman LS, Gilman A, 6th edition, New York, MacMillan Publishing Co, 1980

    Google Scholar 

  12. Wessler S, Gitel S: Control of heparin therapy. Prog Hemost Thromb 3: 311, 1976

    PubMed  CAS  Google Scholar 

  13. King DJ, Kelton JG: Heparin-associated thrombocytopenia. Ann Intern Med 100: 535, 1984

    PubMed  CAS  Google Scholar 

  14. Best CH: Heparin and thrombosis. Br Med J 2: 977, 1938

    PubMed  CAS  Google Scholar 

  15. Moolten SE, Vroman L, Vroman GMS: Role of blood platelets in thromboembolism. Arch Intern Med 84: 667, 1949

    CAS  Google Scholar 

  16. O’Brien JR, Shoobridge SM, Finch WJ: Comparison of the effect of heparin and citrate on platelet aggregation. J Clin Path 22, 1969

    Google Scholar 

  17. Bowie EJW, Owen CA, Thompson JH: A test of platelet adhesiveness. Mayo Clin Proc 44: 306, 1969

    PubMed  CAS  Google Scholar 

  18. Salzman EW: Measurement of platelet adhesiveness. A simple in vitro technique demonstrating an abnormality in von Willebrand’s disease. J Lab Clin Med 62: 724, 1963

    PubMed  CAS  Google Scholar 

  19. Thomson C, Forbes CD, Prentice CR: The potentiation of platelet aggregation by heparin in vitro and in vivo. Clin Sci Mol Med 45: 485, 1973

    PubMed  CAS  Google Scholar 

  20. Lindsay RM, Prentice CRM, Ferguson D, Muir WM, McNicol GP: A method for the measurement of platelet adhesiveness by use of dialysis membranes in a test-cell. Br J Haematol 24: 377, 1973

    PubMed  CAS  Google Scholar 

  21. Lindsay RM, Rourke JTB, Reid BD, Linton AL, Gilchrist T, Courtney J, Edwards RO: The role of heparin on platelet retention by acrylonitrile co-polymer dialysis membranes. J Lab Clin Med 89: 4, 1977

    Google Scholar 

  22. Loeliger EA: ICSH/ICTH recommendations for reporting prothrombin time in oral anticoagulant control. Acta Haematol (Basel) 72: 405, 1984

    PubMed  CAS  Google Scholar 

  23. Barrow DA, Maynard JR: Standardisation of the prothrombin time for monitoring oral anticoagulant therapy: the international normalised ratio. Dade Coagulation Technical Bulletin #19, 1987

    Google Scholar 

  24. Sherry S, Bell WR, Duckert H, Fletcher P, Gurewich V, Marder VJ, Roberts H, Salzman EW, Sasahara A, Verstraete M: Thrombolytic therapy in thrombosis: a National Institutes of Health Consensus Development Conference. Ann intern Med 93: 141, 1980

    Google Scholar 

  25. Bell WR, Meek AG: Guidelines for the use of thrombolytic agents. N Engl J Med 301: 1266, 1979

    PubMed  CAS  Google Scholar 

  26. Marder VJ: The use of thrombolytic agents: choice of patient drug administration, laboratory monitoring. Ann Intern Med 90: 802, 1979

    PubMed  CAS  Google Scholar 

  27. Macfarlane RG, Pilling J: Fibrinolytic activity of normal urine. Nature 159: 779, 1947

    PubMed  CAS  Google Scholar 

  28. Williams JRB: The fibrinolytic activity of urine. Br J Exp Pathol 32: 530, 1951

    PubMed  CAS  Google Scholar 

  29. Sobel GW, Möhler SR, Jones NW, Dowdy AB, Guest MM: Urokinase: an activator of plasma Profibrinolysin extracted from urine. Am J Physiol 171: 768, 1952

    Google Scholar 

  30. Thorsen S, Glas-Greenwalt P, Astrup T: Differences in the binding to fibrin of urokinase and tissue plasminogen activator. Thromb Diath Haemorrh 28: 65, 1972

    PubMed  CAS  Google Scholar 

  31. Risius B, Graor RA, Geisinger MA, Zelch MG, Lucas FV, Young JR, Grossbard EB: Recombinant human tissue-type plasminogen activator for thrombolysis in peripheral arteries and bypass grafts. Radiology 160: 183, 1986

    PubMed  CAS  Google Scholar 

  32. Collen D, Topol EJ, Tiefenbrunn AJ, Gold HK, Weisfeldt ML, Sobel BE, Leinbach RC, Brinker JA, Ludbrook PA, Yasuda I, Bulkley BH, Robison AK, Hutter AM Jr, Bell WR, Spadaro JJ Jr, Khaw BA, Grossbard EB: Coronary thrombolysis with recombinant human tissue-type plasminogen activator: a prospective, randomized, placebo-controlled trial. Circulation 70: 1012, 1984

    PubMed  CAS  Google Scholar 

  33. Moncada S, Gryglewski R, Bunting S, Vane JR: An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature 263: 663, 1976

    PubMed  CAS  Google Scholar 

  34. Johnson RA, Morton DR, Kinner JH, Gorman RR, McGuire JC, Sun FF, Whitaker N, Bunting S, Salman J, Moncada S, Vane JR: The chemical structure of prostaglandin X (prostacyclin). Prostaglandins 12: 915, 1976

    PubMed  CAS  Google Scholar 

  35. Moncada S, Herman AG, Higgs EA, Vane JR: Differential formation of prostacyclin (PGx or PGI2) by layers of the arterial wall: An explanation for the anti-thrombotic properties of vascular endothelium. Thromb Res 11: 323, 1977

    PubMed  CAS  Google Scholar 

  36. Maclntyre DE, Pearson JD, Gordon JL: Localisation and stimulation of prostacyclin production in vascular cells. Nature 271: 549, 1978

    Google Scholar 

  37. Armstrong JN, Lattimer N, Moncada S, Vane JR: Comparison of the vasodepressor effects of prostacyclin and 6-oxyl-prostaglandin F1 alpha with those of prostaglandin E2 in rats and rabbits. Br J Pharmacol 62: 125, 1978

    PubMed  CAS  Google Scholar 

  38. Cazenave JP, Dejana E, Kinlough-Rathbone RL, Richardson M, Packham MA, Mustard JF: Prostaglandins I2 and E1 reduce rabbit and human platelet adherence without inhibiting serotonin release from adherent platelets. Thromb Res 15: 273, 1979

    PubMed  CAS  Google Scholar 

  39. Higgs EA, Moncada S, Vane JR, Caen JP, Michel H, Tobelem G: Effect of prostacyclin (PGI2) and platelet adhesion to rabbit arterial subendothelium. Prostaglandins 16: 17, 1978

    PubMed  CAS  Google Scholar 

  40. Weiss HJ, Turitto VT: Prostacyclin (prostaglandin I2, PGI2) inhibits platelet adhesion and thrombus formation on subendothelium. Blood 53: 244, 1979

    PubMed  CAS  Google Scholar 

  41. Higgs EA, Higgs GA, Moncada S, Vane JR: Prostacyclin (PGI2) inhibits the formation of platelet thrombi in arterioles and venules of the hamster cheek pouch. Br J Pharmacol 63: 535, 1978

    PubMed  CAS  Google Scholar 

  42. Aspirin and other antiplatelet drugs in the prophylaxis of thrombosis. Blood Rev 1: 9, 1987

    Google Scholar 

  43. Goodnight SH, Harris WS, Connor WE: The effects of dietary W3 fatty acids on platelet composition and function in man. A prospective controlled study. Blood 58: 880, 1981

    PubMed  CAS  Google Scholar 

  44. Fuster V, Chesebro JH: Series on pharmacology in practice. 10. Anti-thrombotic therapy: role of platelet-inhibitor drugs. 11. Pharmacological effects of platelet-inhibitor drugs. Mayo Clin Proc 56: 185, 1981

    PubMed  CAS  Google Scholar 

  45. Harker LA, Slichter SJ: Platelet and fibrinogen consumption in man. N Engl J Med 287: 999, 1972

    PubMed  CAS  Google Scholar 

  46. Harker LA: In vivo evaluation of antithrombotic therapy in man. Thromb Diath Haemorrh (suppl 60): 481, 1974

    Google Scholar 

  47. Moncada S, Korbut R: Dipyridamole and other phosphodiesterase inhibitors act as antithrombotic agents by potentiating endogenous prostacyclin. Lancet 1: 1286, 1978

    PubMed  CAS  Google Scholar 

  48. Riesman D: Hemorrhages in the course of Bright’s disease with a nephrotic origin. Am J Med Sci 134: 709, 1907

    Google Scholar 

  49. Donner L, Neuwirtova: The hemostatic defect of acute and chronic uraemia. Thromb Diath Haemorrh 5: 319, 1960

    PubMed  CAS  Google Scholar 

  50. Rabiner SF: Uremic bleeding. Prog Hemost Thromb 1: 233, 1972

    PubMed  CAS  Google Scholar 

  51. Castaldi PA, Rosenberg MC, Stewart JH: The bleeding disorder of uraemia. Lancet 2: 66, 1966

    PubMed  CAS  Google Scholar 

  52. Salzman EW, Neri LL: Adhesiveness of blood platelets in uremia. Thromb Diath Haemorrh 15: 84, 1966

    PubMed  CAS  Google Scholar 

  53. George CRP, Slichter SJ, Quadracci LJ, Striker GE, Harker LA: A kinetic evaluation of hemostasis in renal disease. N Engl J Med 291: 1111, 1974

    PubMed  CAS  Google Scholar 

  54. Stewart JH, Castaldi PA: Uraemic bleeding: A reversible platelet defect corrected by dialysis. Q J Med 36: 409, 1967

    PubMed  CAS  Google Scholar 

  55. Rabiner SF, Hrodek O: Platelet factor 3 in normal subjects and patients with renal failure. J Clin Invest 47: 901, 1968

    PubMed  CAS  Google Scholar 

  56. Joist JH, Pechan J, Schikowski U, Hubner G, Gross R: Studies on the nature and etiology of uremic thrombocytopathy. Verh Dtsch Ges Inn Med 75: 476, 1969

    PubMed  CAS  Google Scholar 

  57. Lindsay RM, Moorthy AV, Koens F, Linton AL: Platelet function in dialyzed and non-dialyzed patients with chronic renal failure. Clin Nephrol 4: 52, 1975

    PubMed  CAS  Google Scholar 

  58. Lindsay RM, Friesen M, Koens F, Linton AL, Oreopoulos D, DeVeber G: Platelet function in patients on long term peritoneal dialysis. Clin Nephrol 6: 335, 1976

    PubMed  CAS  Google Scholar 

  59. Lindsay RM, Friesen M, Aronstam A, Andrus F, Clark WF, Linton AL: Improvement of platelet function by increased frequency of hemodialysis Clin Nephrol 10: 67, 1978

    PubMed  CAS  Google Scholar 

  60. Nenci GG, Berrettini M, Agnelli G, Parise P, Buoncristiani U, Ballatori E: Effect of peritoneal dialysis, haemodialysis and kidney transplantation on blood platelet function. I. Platelet aggregation by ADP and epinephrine. Nephron 23: 287, 1979

    PubMed  CAS  Google Scholar 

  61. Jorgenson KA, Ingeberg S: Platelets and platelet function in patients with chronic ureamia on maintenance hemodialysis. Nephron 23: 233, 1979

    Google Scholar 

  62. Kazatchkine M, Sultan Y, Caen JP, Bariety J: Bleeding in renal failure: a possible cause. Br Med J 2: 612, 1976

    PubMed  CAS  Google Scholar 

  63. Remuzzi G, Pusineri F: Coagulation defects in uremia. Kidney Int 33 (Suppl 24): S123, 1988

    Google Scholar 

  64. Remuzzi G, Livio M, Cavenaghi AE, Marchesi D, Mecca G, Donati MB, de Gaetano G: Unbalanced prostaglandin synthesis and plasma factors in uraemic bleeding a hypothesis. Thromb Res 13: 531, 1978

    PubMed  CAS  Google Scholar 

  65. Di Minno G, Martinez J, McKean ML, De La Rosa J, Burke JF, Murphy S: Platelet dysfunction in uremia. Multifaceted defect partially corrected by dialysis. Am J Med 79: 552, 1985

    PubMed  Google Scholar 

  66. Duke WW: The relation of blood platelets to hemorrhagic disease. JAMA 60: 1185, 1910

    Google Scholar 

  67. Livio M, Gotti E, Marchesi D, Mecca G, Remuzzi G, De Gaetano G: Uremic bleeding: role of anemia and beneficial effect of red cell transfusions. Lancet 2: 1013, 1982

    PubMed  CAS  Google Scholar 

  68. Fernandez F, Goudable C, Sie P, Ton-That H, Durand D, Sue JM, Boneu B: Low hematocrit and prolonged bleeding time in uremic patients: effect of red cell transfusions. Br J Hematol 59: 139, 1985

    CAS  Google Scholar 

  69. Moia M, Vizzotto L, Cattaneo M, Mannucci PM, Cassati S, Pontichelli C: Improvement in the hemostatic defect of uremia after treatment with recombitant human erythropoeitin. Lancet 2: 1127, 1987

    Google Scholar 

  70. Brash JL, Lyman DJ: Adsorption of proteins and lipids to non-biological surfaces, in The Chemistry of Biosurfaces, edited by Hair ML, New York, Marcel Dekker Inc, 1971, p 177

    Google Scholar 

  71. Salzman EW: Role of platelets in blood-surface interactions. Fee Proc 30: 1503, 1971

    CAS  Google Scholar 

  72. Vroman L, Adams AL, Klings M: Interactions among human blood proteins at interfaces. Fed Proc 30: 1494, 1971

    PubMed  CAS  Google Scholar 

  73. Feijen J: Thrombogenesis caused by blood-foreign surface interaction, in Artificial Organs, edited by Kenedi RM, Courtney JM, Gaylor JDS, Gilchrist T, Baltimore, Univ Park Press, 1976, p 235

    Google Scholar 

  74. Niemetz J, Muhlfelder T, Chierego ME, Troy B: Procoagulant activity of leukocytes. Ann NY Acad Sci 283: 208, 1977

    CAS  Google Scholar 

  75. Craddock PR, Fehr J, Brigham KL, Kronenberg RS, Jacob HS: Complement and leukocyte-mediated pulmonary dysfunction in hemodialysis. N Engl J Med 296: 769, 1977

    PubMed  CAS  Google Scholar 

  76. Jacob HS, Craddock PR, Hammerschmidt DE, Moldow DF: Complement-induced granulocyte aggregation: an unsuspected mechanism of disease. N Engl J Med 302: 89, 1980

    Google Scholar 

  77. Lindsay RM, Prentice CRM, Davidson JF, Burton JA, McNicol GP: Haemostatic changes during dialysis associated with the thrombus formation on dialysis membranes. Br Med J 4: 454, 1972

    PubMed  CAS  Google Scholar 

  78. Lindsay RM, Ferguson D, Prentice CRM, Burton JA, McNicol GP: Reduction of thrombus formation on dialyzer membranes by aspirin and RA233. Lancet 2: 1287, 1972

    PubMed  CAS  Google Scholar 

  79. Lindsay RM, Rourke J, Reid B, Friesen M, Linton AL, Courtney J, Gilchrist T: Platelets, foreign surfaces and heparin. Trans Am Soc Artif Intern Organs 22: 292, 1976

    PubMed  CAS  Google Scholar 

  80. Wilkinson R, Lindsay RM, Burton JA: The membrane support system and thrombus formation on dialysis membranes. Proc Eur Dial Transplant Assoc 10: 306, 1973

    PubMed  CAS  Google Scholar 

  81. Gotch FA, Keen ML: Precise control of minimal heparinization for high bleeding risk hemodialysis. Trans Am Soc Artif Intern Organs 23: 168, 1977

    PubMed  CAS  Google Scholar 

  82. Harada K, Zucker MB: Simultaneous development of PF4 activity and release of 14C-serotonin. Thromb Diath Haemorrh 25: 41, 1971

    PubMed  CAS  Google Scholar 

  83. Rucinski B, Niewiarowski J, James P, Walz DA, Budzynski AZ: Antiheparin proteins secreted by human platelets: purification, characterization, and radioimmunoassay. Blood 53: 47, 1979

    PubMed  CAS  Google Scholar 

  84. O’Brien JR: Antithrombin III and heparin clotting times in atherosclerosis and thrombosis. Thromb Diath Haemorrh 32: 116, 1974

    PubMed  Google Scholar 

  85. Aronstam A, Dennis B, Friesen MJ, Clark WF, Linton AL, Lindsay RM: Heparin neutralizing activity in patients with renal disease on maintenance haemodialysis. Thromb Diath Haemorrh 35: 695, 1978

    Google Scholar 

  86. Woods HF, Ash G, Weston MJ, Bunting S, Moncada S, Vane JR: Prostacyclin can replace heparin in haemodialysis in dogs. Lancet 2: 1075, 1978

    PubMed  CAS  Google Scholar 

  87. Turney JH, Fewell MR, Williams LC, Parsons V, Weston MH: Platelet protection and heparin sparing with prostacylin regular dialysis therapy. Lancet 2: 219, 1980

    PubMed  CAS  Google Scholar 

  88. Zusman RM, Rubin RH, Cato AE, Cocchetto DM, Crow JW, Tolkoff-Rubin N: Haemodialysis using prostacyclin instead of heparin as the sole antithrombotic agent. N Engl J Med 304: 934, 1981

    PubMed  CAS  Google Scholar 

  89. Rylance PB, Gordge MP, Ireland H, Lane DA, Weston MJ: Haemodialysis with prostacyclin (Epoprostenol) alone Proc Eur Dial Transplant Assoc Eur Renal Assoc 21: 281, 1984

    Google Scholar 

  90. Lindsay RM: Variable heparin requirements during hemodialysis-Why? asaio J 3: 81, 1980

    Google Scholar 

  91. Glaser P, Guedsder R, Rouby J, Eurin VB: Hemodialysis without heparin is possible. Lancet 1: 579, 1979

    Google Scholar 

  92. Sanders PW, Taylor H, Curtis J: Hemodialysis without anticoagulation. Am J Kidney Dis 5: 32, 1985

    PubMed  CAS  Google Scholar 

  93. Schwab SJ, Onorato JJ, Sharar LR, Dennis PA: Hemodialysis without anticoagulation: 1 year prospective trial in hospitalized patients at risk for bleeding. Am J Med 83: 405, 1987

    PubMed  CAS  Google Scholar 

  94. Caruana RJ, Raiai RM, Bush JV, Kramer MS, Goldstein SJ: Heparin free dialysis: comparative data and results in high risk patients. Kidney Int 31: 1351, 1987

    PubMed  CAS  Google Scholar 

  95. Hall GH, Holman HM, Webster ADB: Anticoagulation by ancrod for haemodialysis. Br Med J 4: 591, 1970

    PubMed  CAS  Google Scholar 

  96. Pinnick RV, Wiegmann TB, Diederich DA: Regional citrate anticoagulation for hemodialysis in the patient at high risk for bleeding. N Engl J Med 308: 258, 1983

    PubMed  CAS  Google Scholar 

  97. von Brecht JH, Flanigan MJ, Freeman RM, Lim VS: Regional anticoagulation: hemodialysis with hypertonic trisodium citrate. Am J Kidney Dis 8: 196, 1986

    Google Scholar 

  98. Kelleher SO, Schulman G: Severe metabolic alkalosis complicated regional citrate hemodialysis. Am J Kidney Dis 9: 235, 1987

    PubMed  CAS  Google Scholar 

  99. Flanigan MJ, von Brecht J, Freeman RM, Lim VS: Reducing the hemorrhagic complications of HD: a controlled comparison of low dose citrate anticoagulation. Am J Kidney Dis 9: 147, 1987

    PubMed  CAS  Google Scholar 

  100. Kaedi A, Pinio GF, Shimizu A, Drivedi H, Hirsch J, Gent M: Arteriovenous shunt thrombosis: Prevention by sulfinpyrazone. N Engl J Med 290: 304, 1974

    Google Scholar 

  101. Harter HR, Burch JW, MajerusPW, Stanford N, Delmez JA, Anderson CB, Weerts CA: Prevention of thrombosis in patients on hemodialysis by low-dose aspirin. N Engl J Med 301: 577, 1979

    PubMed  CAS  Google Scholar 

  102. Wing AJ, Curtis JR, de Wardener HE: Reduction of clotting in Scribner shunts by long-term anticoagulation. Br Med J 3: 143, 1976

    Google Scholar 

  103. Clagett GP, Russo M, Hufnagel H: Platelet changes after placement of aortic prostheses in dogs. I. Biochemical and functional alterations. J Lab Clin Med 97: 345, 1981

    PubMed  CAS  Google Scholar 

  104. Harker LA, Slichter S, Sauvage LR: Platelet consumption by arterial prostheses: The effects of endothelialization and pharmocologic inhibition of platelet function. Ann Surg 186: 594, 1977

    PubMed  CAS  Google Scholar 

  105. Oblath RW, Buckley FO, Green RM, Schwartz SI, DeWeese J A: Prevention of platelet aggregation and adherence to prosthetic vascular grafts by aspirin and dipyridamole. Surgery 84: 37, 1978

    PubMed  CAS  Google Scholar 

  106. Clunie GJA, Martin AM, Nolan B: Intermittent haemodialysis: insertion and care of the Silastic Teflon cannula. Br Med J 3(Suppl July–Sept): 88, 1967

    PubMed  CAS  Google Scholar 

  107. Anderson DC, Martin AN, Clunie GJA, Stewart WK, Robson AS: The use of streptokinase in the declotting of arteriovenous shunts. Proc Eur Dial Transplant Assoc 4: 55, 1967

    CAS  Google Scholar 

  108. Watt DL, Dun BP, Livingston WR, MacDougall Al, MacKay RKS, Obineche EN, Rennie JB: The use of urokinase in declotting arteriovenous shunts. Proc Eur Dial Transplant Assoc 6: 88, 1969

    Google Scholar 

  109. Mcintosh CS, Petrie JC, MacLeod N: Maintenance of SilasticTeflon shunts for intermittent haemodialysis. Br Med J 4: 717, 1969

    PubMed  CAS  Google Scholar 

  110. Clunie GJA, Hartley L: Treatment of clotting in external-arteriovenous shunts with a fibrinolytic enzyme. Med J Aust 2: 463, 1969

    Google Scholar 

  111. Larm O, Larsson R, Olsson P: A new non-thrombogenic surface prepared by selective covalent binding of heparin via a modified reducing terminal residue. Biomat Med Devices Artif Organs 11: (2 and 3), 1984

    Google Scholar 

  112. Lindsay RM, Mason R, Kim SW, Andrade JD, Hawkin RM: Blood surface interactions. Trans Am Soc Artif Intern Organs 26: 603, 1980

    PubMed  CAS  Google Scholar 

  113. ten Cate H, Henny CP, ten Cate JW, Buller HR, Mooy MC, Surachno S, Wilmink JM: Anticoagulant effects of a low molecular weight heparinoid (Org 10172) in human volunteers and dialysis patients. Thromb Res 39: 211, 1985

    PubMed  Google Scholar 

Download references

Authors
  1. Robert M. Lindsay
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anne M. Smith
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Nephrology Division, F. Edward Hébert School of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD, USA

    John F. Maher M.D., FACP (Professor of Medicine, Director) (Professor of Medicine, Director)

Rights and permissions

Reprints and permissions

Copyright information

© 1989 Kluwer Academic Publishers

About this chapter

Cite this chapter

Lindsay, R.M., Smith, A.M. (1989). Practical use of Anticoagulants. In: Maher, J.F. (eds) Replacement of Renal Function by Dialysis. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-1087-4_11

Download citation

  • DOI: https://doi.org/10.1007/978-94-009-1087-4_11

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-6979-3

  • Online ISBN: 978-94-009-1087-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation